Status:
UNKNOWN
Multimodal Neuromonitoring
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
Karl Landsteiner Institute for Clinical Epilepsy Research
Conditions:
Subarachnoid Hemorrhage
Intracerebral Hemorrhage
Eligibility:
All Genders
18-80 years
Brief Summary
Theoretical Framework \& Background Cortical spreading depressions (CSD) and seizures, are crucial in the development of delayed cerebral ischemia and poor functional outcome in patients suffering fr...
Eligibility Criteria
Inclusion
- Individuals between 18-80 years with poor grade aneurysmal SAH (World Federation Neurosurgical Societies \>3), severe ICH (ICH Score \>3) or severe TBI (Glasgow Coma Scale \< 9). The diagnosis of SAH, ICH and TBI will be established by computed tomography (CT).
- Individuals that are unlikely to regain consciousness within the following 48 hours.
- Individuals that are expected to survive for the next 48 hours.
Exclusion
- Individuals younger than 18 years old and older than 80 years.
- Pregnant women (documented via positive ß-HCG test).
- Patients, who do not want to participate in the study. As the patient is not able to consent prior to the study, information about the study details will be given to the patient in case of clinical improvement. The patient information sheet will be handed out.
- Thereafter, the patient has the possibility to withdraw permission of study-participation.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04737369
Start Date
December 1 2020
End Date
December 1 2025
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurosurgery, Medical University of Vienna
Vienna, Austria, 1090